Search research articles
Contact Us
Filters
Showing results (411-420 of 726) with videos related to
Page
of 73
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 1, 1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients
K V Rolston, B LeBlanc, G Gooch, et al.
Cancer Treatment Reports
|
November 1, 1985
Aclarubicin given as continuous infusion in non-small cell bronchogenic carcinoma
D F Chiuten, T Umsawasdi, H M Dhingra, et al.
Reviews of Infectious Diseases
|
May 1, 1985
Bacteremia caused by Aeromonas species in hospitalized cancer patients
R L Harris, V Fainstein, L Elting, et al.
The American Journal of Medicine
|
November 29, 1985
Ticarcillin plus clavulanic acid in the treatment of patients with cancer
V Fainstein, L Elting, S Pitlik, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1985
Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts
K Rolston, R Bolivar, V Fainstein, et al.
Cancer Treatment Reports
|
June 1, 1985
Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combination
D F Chiuten, M Valdivieso, A Bedikian, et al.
Infection Control and Hospital Epidemiology
|
April 1, 1992
Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia
I Raad, S Davis, A Khan, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones
N Dholakia, K V Rolston, D H Ho, et al.
The Journal of Infectious Diseases
|
August 1, 1993
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement
I Raad, W Costerton, U Sabharwal, et al.
Cancer
|
May 15, 1981
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy
G P Bodey, V Rodriguez, W K Murphy, et al.
Page
of 73
Search research articles
Search
Showing results (411-420 of 726) with videos related to
Sort By:
Page
of 73
The Journal of Antimicrobial Chemotherapy
|
March 1, 1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients
K V Rolston, B LeBlanc, G Gooch, et al.
Cancer Treatment Reports
|
November 1, 1985
Aclarubicin given as continuous infusion in non-small cell bronchogenic carcinoma
D F Chiuten, T Umsawasdi, H M Dhingra, et al.
Reviews of Infectious Diseases
|
May 1, 1985
Bacteremia caused by Aeromonas species in hospitalized cancer patients
R L Harris, V Fainstein, L Elting, et al.
The American Journal of Medicine
|
November 29, 1985
Ticarcillin plus clavulanic acid in the treatment of patients with cancer
V Fainstein, L Elting, S Pitlik, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1985
Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts
K Rolston, R Bolivar, V Fainstein, et al.
Cancer Treatment Reports
|
June 1, 1985
Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combination
D F Chiuten, M Valdivieso, A Bedikian, et al.
Infection Control and Hospital Epidemiology
|
April 1, 1992
Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia
I Raad, S Davis, A Khan, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones
N Dholakia, K V Rolston, D H Ho, et al.
The Journal of Infectious Diseases
|
August 1, 1993
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement
I Raad, W Costerton, U Sabharwal, et al.
Cancer
|
May 15, 1981
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy
G P Bodey, V Rodriguez, W K Murphy, et al.
Page
of 73